KEGG   DRUG: Rilotumumab
Entry
D09659                      Drug                                   
Name
Rilotumumab (USAN/INN)
Formula
C6464H9932N1708O2010S46
Exact mass
145115.4623
Mol weight
145205.2525
Sequence
(Heavy chain)
QVQLQESGPG LVKPSETLSL TCTVSGGSIS IYYWSWIRQP PGKGLEWIGY VYYSGSTNYN
PSLKSRVTIS VDTSKNQFSL KLNSVTAADT AVYYCARGGY DFWSGYFDYW GQGTLVTVSS
ASTKGPSVFP LAPCSRSTSE STAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
GLYSLSSVVT VPSSNFGTQT YTCNVDHKPS NTKVDKTVER KCCVECPPCP APPVAGPSVF
LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVQFNWYVDG VEVHNAKTKP REEQFNSTFR
VVSVLTVVHQ DWLNGKEYKC KVSNKGLPAP IEKTISKTKG QPREPQVYTL PPSREEMTKN
QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPMLDSD GSFFLYSKLT VDKSRWQQGN
VFSCSVMHEA LHNHYTQKSL SLSPGK
(Light chain)
EIVMTQSPAT LSVSPGERAT LSCRASQSVD SNLAWYRQKP GQAPRLLIYG ASTRATGIPA
RFSGSGSGTE FTLTISSLQS EDFAVYYCQQ YINWPPITFG QGTRLEIKRT VAAPSVFIFP
PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
(Disulfide bridge: H22-H95, H147-H203, H260-H320, H366-H424, H222-H'222, H223-H'223, H226-H'226, H229-H'339, L23-L88, L135-L195, H134-L215)
  Type
Peptide
Efficacy
Antineoplastic, Anti-hepatocyte growth factor antibody
  Type
Monoclonal antibody
Target
HGF [HSA:3082] [KO:K05460]
  Pathway
hsa04510  Focal adhesion
hsa05200  Pathways in cancer
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokines
   Growth factors (RTK-binding)
    HGF
     D09659  Rilotumumab (USAN/INN)
Other DBs
CAS: 872514-65-3
PubChem: 124490399
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system